Maintaining The Brain's Wiring In Ageing And Disease

Maintaining The Brain's Wiring In Ageing And Disease
Researchers at the Babraham Institute near Cambridge, supported by the Alzheimer's Research Trust and the Biotechnology and Biological Sciences Research Council (BBSRC), have discovered that the brain's circuitry survives longer than previously thought in diseases of ageing such as Alzheimer's disease. The findings were published in the journal Brain. Alzheimer's disease causes nerve cells in the brain to die, resulting in problems with memory, speech and understanding.

Sufferers Of Dementia Benefit From Mix Of Taiji, Cognitive Therapy And Support Groups
Those diagnosed with early stage dementia can slow their physical, mental and psychological decline by taking part in therapeutic programs that combine counseling, support groups, Taiji and qigong, researchers report. Some of the benefits of this approach are comparable to those achieved with anti-dementia medications. The findings are detailed in the American Journal of Alzheimer's Disease and Other Dementias.

Some Home Remedies For Acid Reflux

It is only natural for us to go looking for professional assistance when face with health problems, but giving a thought to some simple procedures that we can do on our own at home to deal with some ailments could go a long way in saving us a lot of money, that which we use to pay medical bills and to buy medicines. When faced with continuous ad persistent acid reflux, you may want to visit your doctor, but wait a minute. Have you tried some of the home remedies for acid reflux?

Wyeth Submits European Marketing Authorization Application For Its 13-Valent Vaccine For The Prevention Of Pneumococcal Disease

Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), announced that it has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMEA) for approval to market its investigational 13-valent pneumococcal conjugate vaccine (PCV13) for infants and young children. Read more ...

RHEI Pharmaceuticals, Inc. announced that the final clinical trial for Tibozole, a locally active antifungal with low dose miconazole in a patented mucoadhesive system, has been initiated in China. This will be the last clinical trial conducted for submission of the New Drug Application (NDA) to the State Food and Drug Administration (SFDA) in China. RHEI licensed Tibozole from Tibotec, a Johnson and Johnson company. Read more ...

Newly formed consortium to advance eradication of inflammatory breast cancer.

The University of Texas M. D. Anderson Cancer Center will hold the first international inflammatory breast cancer (IBC) conference on December 6-7, to bring together internationally recognized breast cancer clinicians and scientists.

Participants will present new clinical discoveries and participate in educational workshops, with the goal of improving diagnosis and management of this rare but deadly disease.

read more

Read more ...

ASM Press announces publication of the latest volume in its popular series on new and emerging infectious diseases. Based on sessions at recent scientific conferences, Emerging Infections 8 offers up-to-date information and the most current research on new and emerging infections that have generated international interest. Read more ...